These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 16395496)
1. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance. Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496 [TBL] [Abstract][Full Text] [Related]
2. Kidney function after nephrectomy for renal cell carcinoma. Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931 [TBL] [Abstract][Full Text] [Related]
3. Predicting postoperative renal insufficiency in patients undergoing nephrectomy for renal malignancy: assessment by renal scintigraphy using 99mtechnetium-mercaptoacetyltriglycine. Shirasaki Y; Saika T; Tsushima T; Nasu Y; Arata R; Kumon H J Urol; 2005 Feb; 173(2):388-90. PubMed ID: 15643177 [TBL] [Abstract][Full Text] [Related]
4. Comparison of camera-based 99mTc-MAG3 and 24-hour creatinine clearances for evaluation of kidney function. Esteves FP; Halkar RK; Issa MM; Grant S; Taylor A AJR Am J Roentgenol; 2006 Sep; 187(3):W316-9. PubMed ID: 16928911 [TBL] [Abstract][Full Text] [Related]
5. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume. Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514 [TBL] [Abstract][Full Text] [Related]
6. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy. Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184 [TBL] [Abstract][Full Text] [Related]
7. The assessment of residual kidney function after living donor nephrectomy. Bieniasz M; Domagala P; Kwiatkowski A; Gozdowska J; Krzysztof O; Kieszek RA; Trzebicki J; Durlik M; Rowinski W; Chmura A Transplant Proc; 2009; 41(1):91-2. PubMed ID: 19249485 [TBL] [Abstract][Full Text] [Related]
8. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy. Mitsui Y; Sadahira T; Araki M; Wada K; Tanimoto R; Ariyoshi Y; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y Clin Exp Nephrol; 2018 Apr; 22(2):453-458. PubMed ID: 28741049 [TBL] [Abstract][Full Text] [Related]
9. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area? Klingensmith WC J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023 [TBL] [Abstract][Full Text] [Related]
10. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats. Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382 [TBL] [Abstract][Full Text] [Related]
11. Effect of warm ischemia on renal function during partial nephrectomy: assessment with new 99mTc-mercaptoacetyltriglycine scintigraphy parameter. Funahashi Y; Hattori R; Yamamoto T; Sassa N; Fujita T; Gotoh M Urology; 2012 Jan; 79(1):160-4. PubMed ID: 22070892 [TBL] [Abstract][Full Text] [Related]
12. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined? Meyer G; Piepsz A; Kolinska J; Lepej J; Sixt R; Hahn K Eur J Nucl Med; 1998 Jul; 25(7):760-5. PubMed ID: 9662599 [TBL] [Abstract][Full Text] [Related]
13. Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted? Werner RA; Bluemel C; Lapa C; Muegge DO; Kudlich T; Buck AK; Herrmann K Nucl Med Commun; 2014 Nov; 35(11):1143-9. PubMed ID: 25171439 [TBL] [Abstract][Full Text] [Related]
14. Risk of live kidney donation--Indian perspective. Sahay M; Narayen G; Anuradha J Assoc Physicians India; 2007 Apr; 55():267-70. PubMed ID: 17694785 [TBL] [Abstract][Full Text] [Related]
15. Prolonged renal parenchymal retention of 99mTc mercaptoacetyltriglycine after nephron-sparing surgery. Inoue Y; Kurimoto S; Kameyama S; Ohta N; Akahane M; Yoshikawa K; Yokoyama I; Minami M; Ohtomo K; Kitamura T Nucl Med Commun; 2004 May; 25(5):509-13. PubMed ID: 15100511 [TBL] [Abstract][Full Text] [Related]
16. Renal outcome 25 years after donor nephrectomy. Goldfarb DA; Matin SF; Braun WE; Schreiber MJ; Mastroianni B; Papajcik D; Rolin HA; Flechner S; Goormastic M; Novick AC J Urol; 2001 Dec; 166(6):2043-7. PubMed ID: 11696703 [TBL] [Abstract][Full Text] [Related]
17. Medical risk analysis of renal transplant donors. Berber I; Tellioglu G; Kilicoglu G; Ozgezer T; Canbakan M; Gulle S; Yigit B; Titiz I Transplant Proc; 2008; 40(1):117-9. PubMed ID: 18261562 [TBL] [Abstract][Full Text] [Related]
18. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine). Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116 [TBL] [Abstract][Full Text] [Related]
19. (99m)Tc-mercaptoacetyl triglycine renography to monitor renal transplant function among kidneys from donors after cardiac death. Majima T; Hattori R; Funahashi Y; Komatsu T; Kato M; Yamada S; Kamihira O; Goto M Transplant Proc; 2012 Jan; 44(1):49-53. PubMed ID: 22310576 [TBL] [Abstract][Full Text] [Related]
20. Computed Tomography Volumetry in Preoperative Living Kidney Donor Assessment for Prediction of Split Renal Function. Wahba R; Franke M; Hellmich M; Kleinert R; Cingöz T; Schmidt MC; Stippel DL; Bangard C Transplantation; 2016 Jun; 100(6):1270-7. PubMed ID: 26356175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]